Form 4: Becton Dickinson Executive Michael Feld Reports Stock and Stock Appreciation Rights Acquisition

Executive Vice President and President of Life Sciences at Becton Dickinson, Michael Feld, reports the acquisition of common stock and stock appreciation rights.

Summary

• Michael Feld, an Executive Vice President and President of Life Sciences at Becton Dickinson, filed a Form 4 indicating changes in his beneficial ownership of company securities.
• On November 26, 2024, Mr. Feld acquired 2,553 shares of common stock and 10,004 stock appreciation rights.
• The common stock was acquired at a price of $0, likely representing a grant of restricted stock units.
• The stock appreciation rights have an exercise price of $224.25 and vest in four annual installments beginning November 26, 2025, and expire on November 26, 2034.
• Following these transactions, Mr. Feld directly owns 9,190 shares of common stock and 10,004 stock appreciation rights.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with company performance. There are no negative implications.

Positives

• The acquisition of stock and stock appreciation rights by a high-ranking executive suggests confidence in the company's future performance.
• The vesting schedule of the stock appreciation rights incentivizes long-term commitment from the executive.

Industry Context

This filing is a routine disclosure of executive compensation and is typical for publicly traded companies. It provides transparency into the equity holdings of key personnel.

Comparison to Industry Standards

• Stock and stock appreciation rights are common forms of executive compensation in the healthcare and medical device industry.
• Companies like Medtronic and Abbott also use similar equity-based compensation plans to align executive interests with shareholder value.
• The vesting schedule of the stock appreciation rights is typical, encouraging long-term performance.

Stakeholder Impact

• The acquisition of stock and stock appreciation rights by an executive may be viewed positively by shareholders as it aligns management's interests with the company's long-term success.
• The vesting schedule of the stock appreciation rights may encourage the executive to focus on long-term value creation.

Key Dates

Keywords

Becton Dickinson, Michael Feld, stock appreciation rights, stock, executive compensation, Form 4, insider trading, equity